Table 2.
Outcome variables at baseline and end-of-study and differences between intervention and control group at the end of intervention.
| Measures | Intervention | Control | |||||
|---|---|---|---|---|---|---|---|
| Baseline | End-of-study | Baseline | End-of-study | Difference+ (95% CI) | P value | Adj P value* | |
| n (SD) | (SD) | n (SD) | (SD) | ||||
| Blood glucose (mg/dl) | 139.4 (75.5) | 152.3 (89.0) | 145.4 (74.2) | 151.4 (88.9) | 5.3 (-23.3 to 33.8) | 0.718 | 0.467 |
| Systolic blood pressure (mmHg) | 104.7 (24.1) | 113.4 (21.9) | 100.9 (20.7) | 107.2 (18.9) | −1.0 (-7.5 to 5.5) | 0.758 | 0.790 |
| Diastolic blood pressure (mmHg) | 73.5 (15.0) | 77.6 (14.4) | 70.8 (13.8) | 74.5 (13.7) | −0.3 (-5.2 to 4.5) | 0.897 | 0.674 |
| Body mass index† | 20.9 (5.7) | 22.4 (4.5) | 20.9 (7.1) | 22.2 (4.9) | −0.1 (-0.9 to 0.7) | 0.778 | 0.536 |
Values are mentioned as mean (SD) unless otherwise stated.
+
Mean difference between Baseline to end of study changes comparing Intervention and Control group.
†
2 missing cases for BMI in Baseline (n = 56 in intervention and n = 62 in control) and 2 missing cases in End line (n = 50 in intervention and n = 53 in control).
*
p-value from the fully adjusted (multivariable) model.